Scientific partners Asthma Prevention
Scientists Asthma Prevention
These scientists are involved in the Asthma Prevention Consortium:
Bart Lambrecht, MD PhD
Professor at Universiteit Gent / VIB
Benjamin Marsland, PhD
Professor at Monash University
Erika von Mutius, MD PhD
Professor at Ludwig-Maximilians-Universität München
Hamida Hammad, PhD
Professor at Universiteit Gent / VIB
Henry McSorley, PhD
University of Dundee
Hermelijn Smits, PhD
Professor at Leids Universitair Medisch Centrum
Markus Ege, MD PhD
Professor at Ludwig-Maximilians-Universität München
Pieter Hiemstra, PhD
Professor at Leids Universitair Medisch Centrum
Rick Maizels, PhD
Professor at University of Glasgow
Translational Committee Asthma Prevention Consortium
The Translational Committee for the Asthma Prevention Consortium was formed with the aim to steer the scientific strategy and expedite the translation of scientific discovery into meaningful health outcomes. Members of the Committee:
- Jeffrey Drazen, MD
Editor-in-Chief of the New England Journal of Medicine
Distinguished Parker B. Francis Professor of Medicine, Harvard Medical School - Paul Peter Tak, PhD, MD
CEO Kintai Therapeutics
Professor of Medicine, University of Amsterdam - Anne Leendertse, PhD
Clinical Pharmacist
Patient representative - René Raggers, PhD
Senior European and Dutch Patent Attorney - Hans Bisgaard, MD, DMSc (sadly passed away)
Professor of Pediatrics
Copenhagen Prospective Studies on Asthma in Childhood (COPSAC)
FLTR Paul Peter Tak, Iman Schultz (Longfonds), Jeffrey Drazen, René Raggers, Anne Leendertse,
Hans Bisgaard*
* Hans Bisgaard has sadly passed away
Patient Advisory Committee Asthma Prevention Consortium
To emphasize the Lung Foundation Netherlands’ commitment to its patient interest agenda, a Patient Advisory Committee (PAC) is actively involved in the Asthma Prevention Consortium. The participation of patient representatives affords the consortium direct insight into the issues and challenges faced by lung patients, esp. asthma. The PAC is responsible for identifying and prioritizing topics to be addressed by the consortium from the patient perspective. Their involvement improves outcomes for lung patients and ensures successful implementation of future products. Members of the Committee (as of April 2019):
- Jesca Groenendijk, the Netherlands
- Anne Leendertse, the Netherlands
- Martine Puhl, the Netherlands
- Amanda Roberts, United Kingdom
- Setareh Ancery-Foumani, the Netherlands
FLTR Anne Leendertse, Martine Puhl, Jesca Groenendijk and Amanda Roberts.
